07 March 2008: The Biosafety Advisory Council issues a positive advice (with conditions) for this trial.
Trial reference:
A multi-centre phase I study to evaluate the safety and tolerability of a heterologous prime-boost vaccination with INX102-3697 HBV pDNA/INX102-0557 HBV MVA in healthy volunteers and HBeAg+ chronic hepatitis patients